Effectiveness Of Leukoreduction And Washed Packed Red Blood Cells on Hemoglobin Increment And Side Effects In Post Transfusion Anemia Patients

Dairion Gatot, Andri Iskandar Mardia

Abstract


Blood transfusion is one of the methods to treat anemia and packed red blood cells (PRC) are the most widely used blood component. Post transfusion results showed that increment of hemoglobin (Hb) does not always match the amount of PRC given. This is thought to be due to the recipient's immune reaction to the PRC component. Leukoreduction is an action to reduce leukocytes from the PRC component thereby reducing the risk of an immune reaction. Alternatively, another method called washed PRC can also be used. In this study, the researcher studied the effectivity of leukoreduction and washed PRC on Hb increase in post-transfusion anemia patients compared with the usual PRC. The researcher used a pre-test post-test group design method of 60 people who were divided into 3 groups (ordinary PRC, washed PRC, leukofiltered PRC). The results showed all three groups reached the transfusion target (a 75% increase in Hb) and there were no differences among the groups both in terms of achievement of the Hb target and the incidence of side effects. There were no differences in the success of transfusion and incidence of side effects among the three groups.


Keywords


leukofilter, leukoreduction, transfusion, washed PRC

Full Text:

PDF

References


Simancas-Racines D, Osorio D, Martí-Carvajal AJ, Arevalo-Rodriguez I. Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion. Cochrane Database of Systematic Reviews 2015 (12)

Bruil A, Beugeling T, Feijen J, Aken WG. The Mechanisms of Leukocyte Removal by Filtration. Transfusion Medicine Reviews 1995; 9(2):145-166

Simon TL, et al. Practice Parameter for the use of Red Blood Cell Transfusions. Arch Patrol LabMed. 1998;122:130-138

Liumbruno G, Benardello F, Lattanzio A, Piccoli P, Rosetti G. Recommendations for the transfusion of Red Blood Cells. Blood Transfus 2009; 7: 49-64

Morris K P, Naqvi N, Davies P, Smith M, Lee P W. A new formula for blood transfusion volume in the critically ill. Arch Dis Child 2005;90:724–728

Cortes B A. Anemia and Transfusions of Red Blood Cells. Colomb Med. 2013; 44(4): 236-41

Bosman G J C G M. Survival of red blood cells after transfusion: processes and consequences. Frontiers in Physiology. 2013;4:1-8

Sharma R R, Marwaha N. Leukoreduced blood components: Advantages and strategies for its implementation in developing countries. Asian J Transfus Sci. 2010 Jan; 4(1): 3–8.

Van de Watering et al. Beneficial Effects of Leukocyte Depletion of Transfusid Blood on PostoperativeComplications in Patients Undergoing Cardiac Surgery : A Randomized Clinical Trial, Circulation. 1998;97:562-568

Sharma AD et al. Leukocyte-Reduced Blood Transfusions: Perioperative Indications, Adverse Effects, and Cost Analysis,Anesth Analg 2000; 90:1315-23




DOI: http://dx.doi.org/10.30596%2Fbf.v6i3.8924

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

BULETIN FARMATERA

Gedung Kampus 1 Fakultas Kedokteran Universitas Muhammadiyah Sumatera Utara | UMSU

Lantai II,Laboratorium Farmakologi dan Terapi FK UMSU-Jalan Gedung Arca No. 53 Medan-Sumatera Utara ,

Kode Pos 20217 Kontak: 0812-6208-2844,E-mail: farmatera@umsu.ac.id


 
Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
View My Stats Buletin Farmatera